(Total Views: 922)
Posted On: 03/22/2021 2:28:10 PM
Post# of 148902
It's just curious that CytoDyn/Amarex would wait nearly 3 months to submit the open-label phase information and then decide to do it on 3/18 in the midst of discussions with the FDA about filing the CD16 protocol. This is what I find intriguing.
(7)
(0)Scroll down for more posts ▼
